第 1 到 32 筆結果,共 32 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; CHEN-HUA LIU ; SIH-HAN LIAO ; CHUN-MING HONG ; Lan, Ting Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Clinical Gastroenterology and Hepatology | 2 | ||
2 | 2023 | Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy | Lin, Meng-Ju; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; JYH-MING LIOU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; CHUN-MING HONG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 1 | |
3 | 2023 | Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months | TUNG-HUNG SU ; Chang, Shan-Han; CHI-LING CHEN ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology research : the official journal of the Japan Society of Hepatology | 1 | 0 | |
4 | 2023 | Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; Lan, Ting-Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology international | 5 | 2 | |
5 | 2023 | Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection | TUNG-HUNG SU ; SHANG-CHIN HUANG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; YAO-MING WU ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
6 | 2022 | Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis | TUNG-HUNG SU ; Peng, Cheng-Yuan; Chang, Shan-Han; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 11 | 10 | |
7 | 2021 | Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; Chen, Tony Hsiu Hsi ; PEI-JER CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 14 | 15 | |
8 | 2020 | Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer | TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | International Journal of Cancer | 4 | 4 | |
9 | 2020 | HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chang C.T; TUNG-HUNG SU ; Yang W.-T; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 32 | |
10 | 2019 | Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; Chou S.-W; CHIN-HSIEN LIN ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; JIA-HORNG KAO | Movement Disorders | 14 | 14 | |
11 | 2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 29 | 26 | |
12 | 2019 | High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Huang Y.-T; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 96 | 76 | |
13 | 2019 | NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging | TUNG-HUNG SU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; Adhoute X; Bourlière M; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 4 | 3 | |
14 | 2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
15 | 2018 | Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 19 | 18 | |
16 | 2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 59 | 52 | |
17 | 2017 | Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 42 | 39 | |
18 | 2016 | Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection | Yang W.-T.; Wu L.-W; TAI-CHUNG TSENG ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Medicine (United States) | 20 | 15 | |
19 | 2016 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Hepatology | 35 | 31 | |
20 | 2015 | Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; Yang W.-T; Tsai C.-S; Kuo S.F.-T; Verbree F.C; TUNG-HUNG SU ; Wang C.-C; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 98 | 84 | |
21 | 2015 | Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; Yang W.-T; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 48 | 43 | |
22 | 2014 | Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 13 | 9 | |
23 | 2013 | Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Hsu C.-A; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 220 | 195 | |
24 | 2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
25 | 2013 | Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | PLoS ONE | 21 | 16 | |
26 | 2013 | Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Yang W.-T; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 45 | 44 | |
27 | 2013 | Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C | TUNG-HUNG SU ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Ting T.-T.; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 53 | 52 | |
28 | 2012 | High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 430 | 381 | |
29 | 2012 | Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 129 | 115 | |
30 | 2012 | Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation | TAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 44 | 43 | |
31 | 2010 | HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses | Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN ; JIA-HORNG KAO ; Lai M.-Y.; CHEN-HUA LIU ; TUNG-HUNG SU ; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Infectious Diseases | 42 | 37 | |
32 | 2010 | Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B | TUNG-HUNG SU ; Hsu C.-S.; CHI-LING CHEN ; CHEN-HUA LIU ; Huang Y.-W.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 78 | 73 |